These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 9394246)

  • 21. IVF in the USA, who pays for it?
    Callens S
    Med Law; 1992; 11(1-2):73-81. PubMed ID: 1522781
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Finance issue brief: mandated benefits: infertility treatment coverage requirements: year end report-2003.
    Plaza CI
    Issue Brief Health Policy Track Serv; 2003 Dec; ():1-6. PubMed ID: 14870749
    [No Abstract]   [Full Text] [Related]  

  • 23. Couples' willingness to pay for IVF/ET.
    Granberg M; Wikland M; Nilsson L; Hamberger L
    Acta Obstet Gynecol Scand; 1995 Mar; 74(3):199-202. PubMed ID: 7900524
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro fertilisation: the major issues.
    Singer P; Wells D
    J Med Ethics; 1983 Dec; 9(4):192-9. PubMed ID: 6668584
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tax credits, insurance, and in vitro fertilization in the U.S. military health care system.
    Wu M; Henne M; Propst A
    Mil Med; 2012 Jun; 177(6):745-7. PubMed ID: 22730853
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Affordability and Accessibility of Ontario's Publicly Funded IVF Program: A Survey of Patients.
    Winsor SP; Ala-Leppilampi K; Spitzer K; Edney DR; Petropanagos A; Cadesky KI; Casper R; Laskin C
    J Obstet Gynaecol Can; 2020 May; 42(5):568-575. PubMed ID: 31843288
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trends in the use of intracytoplasmic sperm injection in the United States.
    Jain T; Gupta RS
    N Engl J Med; 2007 Jul; 357(3):251-7. PubMed ID: 17634460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro fertilization: a cross-sectional analysis of 58 US insurance companies.
    Ha M; Drees A; Myers M; Finkelstein ER; Dandulakis M; Reindorf M; Roque DM; Beall SA; Slezak S; Rasko YM
    J Assist Reprod Genet; 2023 Mar; 40(3):581-587. PubMed ID: 36542313
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Resource allocation of in vitro fertilization: a nationwide register-based cohort study.
    Klemetti R; Gissler M; Sevón T; Hemminki E
    BMC Health Serv Res; 2007 Dec; 7():210. PubMed ID: 18154645
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Desire for a child and desired children--possibilities and limits of reproductive biomedicine].
    Krones T; Neuwohner E; El Ansari S; Wissner T; Richter G
    Ethik Med; 2006 Mar; 18(1):51-62. PubMed ID: 17153251
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Funding in vitro fertilization treatment for persistent subfertility: the pain and the politics.
    Hughes EG; Giacomini M
    Fertil Steril; 2001 Sep; 76(3):431-42. PubMed ID: 11532460
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Resources for infertility treatment.
    Winston RM
    Baillieres Clin Obstet Gynaecol; 1991 Sep; 5(3):551-73. PubMed ID: 1954728
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cost-effectiveness of IVF infertility treatment in different legislative settings].
    Kurzawa R; Kuczyński W; Pawelczyk L; Wołczyński S
    Ginekol Pol; 2010 Feb; 81(2):125-30. PubMed ID: 20232711
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Health Care Access, Costs, and Treatment Dynamics: Evidence from In Vitro Fertilization.
    Hamilton BH; Jungheim E; McManus B; Pantano J
    Am Econ Rev; 2018 Dec; 108(12):3725-77. PubMed ID: 30497124
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Should insurance coverage for in vitro fertilization be mandated?
    Guzick DS
    N Engl J Med; 2002 Aug; 347(9):686-8. PubMed ID: 12200559
    [No Abstract]   [Full Text] [Related]  

  • 36. Out-of-Pocket and Health Care Spending Changes for Patients Using Orally Administered Anticancer Therapy After Adoption of State Parity Laws.
    Dusetzina SB; Huskamp HA; Winn AN; Basch E; Keating NL
    JAMA Oncol; 2018 Jun; 4(6):e173598. PubMed ID: 29121177
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A cost-effectiveness analysis of freeze-only or fresh embryo transfer in IVF of non-PCOS women.
    Le KD; Vuong LN; Ho TM; Dang VQ; Pham TD; Pham CT; Norman RJ; Mol BWJ
    Hum Reprod; 2018 Oct; 33(10):1907-1914. PubMed ID: 30239784
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is IVF-served two different ways-more cost-effective than IUI with controlled ovarian hyperstimulation?
    Tjon-Kon-Fat RI; Bensdorp AJ; Bossuyt PM; Koks C; Oosterhuis GJ; Hoek A; Hompes P; Broekmans FJ; Verhoeve HR; de Bruin JP; van Golde R; Repping S; Cohlen BJ; Lambers MD; van Bommel PF; Slappendel E; Perquin D; Smeenk J; Pelinck MJ; Gianotten J; Hoozemans DA; Maas JW; Groen H; Eijkemans MJ; van der Veen F; Mol BW; van Wely M
    Hum Reprod; 2015 Oct; 30(10):2331-9. PubMed ID: 26269539
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The willingness to pay for in vitro fertilization: a pilot study using contingent valuation.
    Neumann PJ; Johannesson M
    Med Care; 1994 Jul; 32(7):686-99. PubMed ID: 8028404
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prioritization of Patients for Publicly Funded IVF in Ontario: A Survey of Fertility Centres.
    Gotz T; Jones C
    J Obstet Gynaecol Can; 2017 Mar; 39(3):138-144. PubMed ID: 28343554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.